![](/img/cover-not-exists.png)
Infliximab Reintroduction is Not Associated to a Higher Rate of Immune-related Adverse Effects in Patients With Inflammatory Bowel Disease Initially Treated With a Three-infusion Induction Regimen
Domènech, Eugeni, Zabana, Yamile, Mañosa, Míriam, Garcia-Planella, Esther, Cabré, Eduard, Gassull, Miquel ÀngelVolume:
44
Language:
english
Journal:
Journal of Clinical Gastroenterology
DOI:
10.1097/mcg.0b013e3181962dfa
Date:
January, 2010
File:
PDF, 167 KB
english, 2010